148 related articles for article (PubMed ID: 34452548)
1. Young Breast Cancer: Novel Gene Methylation in WBC.
Noruzinia M; Tavakkoly-Bazzaz J; Ahmadvand M; Azimi F; Dehghanifard A; Khakpour G
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2371-2375. PubMed ID: 34452548
[TBL] [Abstract][Full Text] [Related]
2. Methylomics of breast cancer: Seeking epimarkers in peripheral blood of young subjects.
Khakpour G; Noruzinia M; Izadi P; Karami F; Ahmadvand M; Heshmat R; Amoli MM; Tavakkoly-Bazzaz J
Tumour Biol; 2017 Mar; 39(3):1010428317695040. PubMed ID: 28349825
[TBL] [Abstract][Full Text] [Related]
3. The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females.
Al-Moghrabi N; Nofel A; Al-Yousef N; Madkhali S; Bin Amer SM; Alaiya A; Shinwari Z; Al-Tweigeri T; Karakas B; Tulbah A; Aboussekhra A
BMC Cancer; 2014 Nov; 14():830. PubMed ID: 25403427
[TBL] [Abstract][Full Text] [Related]
4. Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.
Li SY; Wu HC; Mai HF; Zhen JX; Li GS; Chen SJ
J Cell Biochem; 2019 Jan; 120(1):658-670. PubMed ID: 30203578
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
Harahap WA; Sudji IR; Nindrea RD
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients.
Fleischer T; Edvardsen H; Solvang HK; Daviaud C; Naume B; Børresen-Dale AL; Kristensen VN; Tost J
Int J Cancer; 2014 Jun; 134(11):2615-25. PubMed ID: 24395279
[TBL] [Abstract][Full Text] [Related]
7.
Lorenzo PM; Izquierdo AG; Diaz-Lagares A; Carreira MC; Macias-Gonzalez M; Sandoval J; Cueva J; Lopez-Lopez R; Casanueva FF; Crujeiras AB
Front Endocrinol (Lausanne); 2020; 11():245. PubMed ID: 32390948
[TBL] [Abstract][Full Text] [Related]
8. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
9. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
10. Methylated DNA immunoprecipitation and microarray-based analysis: detection of DNA methylation in breast cancer cell lines.
Weng YI; Huang TH; Yan PS
Methods Mol Biol; 2009; 590():165-76. PubMed ID: 19763503
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
[TBL] [Abstract][Full Text] [Related]
12. Methylation of Glutathione-S-Transferase P1 Promotor in Egyptian Females with Breast Cancer.
Moghazy TF; ElAttar HA; Eldeeb MK; Rashad RM; Farouk AM; Farag AM
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2523-2530. PubMed ID: 31450928
[TBL] [Abstract][Full Text] [Related]
13. Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients.
Cho YH; Yazici H; Wu HC; Terry MB; Gonzalez K; Qu M; Dalay N; Santella RM
Anticancer Res; 2010 Jul; 30(7):2489-96. PubMed ID: 20682973
[TBL] [Abstract][Full Text] [Related]
14. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
15. Epigenome-wide DNA methylation and risk of breast cancer: a systematic review.
Ennour-Idrissi K; Dragic D; Durocher F; Diorio C
BMC Cancer; 2020 Oct; 20(1):1048. PubMed ID: 33129307
[TBL] [Abstract][Full Text] [Related]
16. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
[TBL] [Abstract][Full Text] [Related]
17. Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population.
Arif T; Anwar N
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2395-2401. PubMed ID: 32856871
[TBL] [Abstract][Full Text] [Related]
18. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
[TBL] [Abstract][Full Text] [Related]
19. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
20. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
